1 Abcellera Biologics Inc Receivables Turnover Ratio (ABCL), from the first quarter 2026 to the first quarter 2025 current and historic results, rankings and more - CSIMarket

Company Name, Ticker, Industry, else..

Growth Rates

Profitability

Valuation Comparisons

Management Effectiveness

Financial Strength

Efficiency

• Sales per Employee

• Income per Employee

• Inventory Turnover

• Asset Turnover

• Receivables Turnover

Dividend Comparisons

Abcellera Biologics Inc (NASDAQ: ABCL)

Sector • Healthcare Industry • Major Pharmaceutical Preparations

Industry • Major Pharmaceutical Preparations

Sector • Healthcare

Abcellera Biologics Inc Accounts Receivables Turnover Ratio from the first quarter 2026 to the first quarter 2025

Quarterly Results, Trends, Rankings, Statistics

According to Abcellera Biologics Inc Balance Sheet, in the first quarter 2026, company has not reported any Accounts receivable.
See Abcellera Biologics Inc Balance Sheet

If we take a look into Healthcare sector 498 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2026 from 0 to 3299.

What is Receivable Turnover Ratio?
What is Abcellera Biologics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ABCL Receivables Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Receivable Change	-	-	-	-	-
Y / Y Revenue Change	96.34 %	788.37 %	37.62 %	133.29 %	-57.45 %
Receivable Turnover Ratio (TTM)	-	-	-	-	-
ABCL's Total Ranking	# 3299	# 0	# 3428	# 3213	# 3325
Accounts Receivable average collection period days	-	-	-	-	-
Seq. Receivable Change	-	-	-	-	-
Seq. Revenue Change	-81.46 %	400.88 %	-47.58 %	303.4 %	-16.12 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 171
Healthcare Sector	# 499
Overall Market	# 3299

Receivable Turnover Ratio Statistics
High	Average	Low
0.4	0.13	0.02
(Sep 30 2022)		(Mar 31 2025)

ABCL Company Profile • Back to ABCL Efficiency Comparisons • Compare ABCL Receivables Turnover Ratio to its Competitors

Financial Statements
Abcellera Biologics Inc 's Accounts Receivable	$ 0 Millions	Visit ABCL's Balance sheet
Abcellera Biologics Inc 's Sales TTM	$ 79 Millions	Visit ABCL's Income Statement
Sources of ABCL's Revenues		Visit ABCL's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ABCL's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ABCL's Growth Rates	ABCL's Roa	ABCL's Inventory Turnover Ratio	ABCL's Dividend Comparisons
ABCL's Profitability Ratios	ABCL's Roi	ABCL's Asset Turnover Ratio	ABCL's Dividend Growth
ABCL's Valuation Ratios	ABCL's Roe	ABCL's Financial Strength Ratios	ABCL's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector

Receivable Turnover Ratio

Revenues for 12 Months ending Mar 31 2026

Receivable at quarter ending Mar 31 2026

Date modified: 2026-06-22T16:30:43+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.